| Literature DB >> 34104644 |
Steven Kakooza1, Adrian Muwonge2, Esther Nabatta1,3, Wilfred Eneku1,4, Dickson Ndoboli1, Eddie Wampande1,3, Damian Munyiirwa1, Edrine Kayaga1, Maria Agnes Tumwebaze1, Mathias Afayoa1,4, Paul Ssajjakambwe4, Dickson Stuart Tayebwa1,4, Sayaka Tsuchida5, Torahiko Okubo6, Kazunari Ushida5, Ken'ichi Sakurai7, Francis Mutebi1,4.
Abstract
There are increasing reports of antimicrobial treatment failures for bacterial diseases of poultry in Uganda. The paucity of data on antimicrobial resistance (AMR) of pathogenic bacteria in Uganda is a major setback to AMR control. This study investigated the occurrence of fowl typhoid, colibacillosis, and AMR in associated pathogens from 2012 to 2018. Laboratory records from the Central Diagnostic Laboratory (CDL), a National Veterinary Diagnostic Facility located at Makerere University, were reviewed. Archived isolates of the causative bacteria for the two diseases were also evaluated for AMR. The frequencies of the two disease conditions, their clinical and necropsy presentations and the demographic data of the diagnostic samples were summarized from the records. Archived bacterial isolates were revived before antimicrobial susceptibility testing. This was done on Mueller Hinton agar using the disk diffusion method, against 16 antimicrobials of medical and veterinary importance according to the Clinical Laboratory Standards Institute guidelines. A total of 697 poultry cases were presented for bacteriological investigations in the review period. Colibacillosis and salmonellosis had prevalence rates of 39.7% (277/697) and 16.2% (113/697), respectively. A total of 63 and 92 isolates of Escherichia coli and Salmonella spp., respectively, were archived but 43 (68.3%) E. coli and 47 (51.1%) Salmonella spp. isolates were recovered and evaluated for AMR. Multidrug resistance was more frequent in E. coli (38; 88.4%) than salmonellae (25; 53.2%), (p < 0.001). The high prevalence of colibacillosis, salmonellosis and the AMR of associated pathogens warrants immediate institution of appropriate disease control measures.Entities:
Keywords: Antimicrobial-resistance; E. coli; Salmonella spp.; Uganda; poultry
Year: 2021 PMID: 34104644 PMCID: PMC8158283 DOI: 10.1080/23144599.2021.1926056
Source DB: PubMed Journal: Int J Vet Sci Med ISSN: 2314-4599
Descriptive information of the poultry cases received for diagnosis by bacterial culture
| Number of cases | Proportion (%) | |
|---|---|---|
| 2012 | 4 | 0.6 |
| 2013 | 65 | 9.3 |
| 2014 | 157 | 22.5 |
| 2015 | 129 | 18.5 |
| 2016 | 163 | 23.4 |
| 2017 | 83 | 11.9 |
| 2018 | 96 | 13.8 |
| Chicken | 692 | 99.28 |
| Duck | 1 | 0.14 |
| Goose | 1 | 0.14 |
| Turkey | 1 | 0.14 |
| Viscera organs | 574 | 82.4 |
| Swabs a | 69 | 9.9 |
| Eggs | 54 | 7.7 |
| Central | 536 | 76.9 |
| Northern | 2 | 0.3 |
| Western | 19 | 2.7 |
| Commercial Broilers | 128 | 18.4 |
| Commercial Layers | 263 | 37.7 |
| Dual purpose | 83 | 11.9 |
a-swab types were nasal, eye, visceral, faecal, joint, cloacal and intestinal and others not-identified, b-Districts of sample origin and corresponding regions included; Central: Gomba, Kalangala, Kalungu, Kampala, Kayunga, Luweero, Masaka, Mityana, Mpigi, Mukono, Wakiso; Nakaseke, Nakasongola; Western: Hoima, Kanungu, Kasese, Kiryandongo, Kiruhura, Masindi, Mbarara, Ntungamo and Northern: Gulu
Figure 1.Major morphological presentations of the detected cases of colibacillosis. 1. Diffuse acute fibrinous peritonitis, perihepatitis and air sacculitis; 2. Localized Chronic fibrinous salpingitis; 3. Bilateral panophthalmitis and 4. Severe obliterative chronic salpingitis
Figure 2.Common morphological presentations of salmonellosis. 1. Greenish discolouration in the liver with multifocal necrotic foci in the parenchyma; 2. Multifocal to diffuse hepatic necrotic foci and hepatic congestion
Prevalence of colibacillosis and salmonellosis in commercial poultry, regions of sample origin, and poultry species
| Variable | Number of Submissions | Diagnosis by bacterial culture | |
|---|---|---|---|
| Colibacillosis (x, %) | Salmonellosis (y, %) [ | ||
| Broiler | 128 | 72 (56.3) | 27 (21.1) |
| Dual | 83 | 30 (36.2) | 21 (25.3) |
| Layers | 263 | 117 (44.5) | 32 (12.2) |
| Data missing | 223 | 58 (26.0) | 33 (14.8) |
| Total | |||
| Central | 536 | 210 (39.2) | 94 (17.5) |
| Northern | 2 | 0 (0.0) | 0 (0.0) |
| Western | 19 | 10 (52.6) | 4 (21.1) |
| Data missing | 140 | 57 (40.7) | 15 (10.7) |
| Chicken | 692 | 277 (40.0) | 113 (16.3) |
| Duck | 1 | 0 (0.0) | 0 (0.0) |
| Goose | 1 | 0 (0.0) | 0 (0.0) |
| Turkey | 1 | 0 (0.0) | 0 (0.0) |
| Data missing | 2 | 0 (0.0) | 0 (0.0) |
CI – Confidence interval, OR – Odds Ratio, a – no computation, *significant predictor for both colibacillosis and salmonellosis.
Comparison of AMR in pathogenic E. coli and Salmonella spp
| Antibiotic resistance type | Family | Number of isolates (%; CI) | ||
|---|---|---|---|---|
| Ampicillin | β-lactams | 24 (55.8; 39.9–70.9) | 11 (23.4;12.3–38.0) | 0.003* |
| Amoxycillin | 38 (88.4;74.9–96.1) | 21 (44.7;30.2–59.9) | < 0.001* | |
| Amoxycillin clavulanic acid | Modified penicillins | 1 (2.3;0.0–12.3) | 10 (21.3;10.7–35.7) | 0.016* |
| Ciprofloxacin | Quinolones | 14 (32.6; 19.1–48.5) | 26 (55.3;40.1–69.8) | 0.05 |
| Nalidixic acid | 28 (65.1;49.1–79.0) | 21 (44.7;30.2–59.9) | 0.083 | |
| Gentamicin | Aminoglycosides | 11 (25.6;13.5–41.2) | 8 (17.0;7.7–30.8) | 0.462 |
| Neomycin | 19 (44.2;29.1–60.1) | 14 (29.8;17.3–44.9) | 0.231 | |
| Cefazolin | Cephalosporins (1st, 2nd, 3rd) | 36 (83.7;69.3–93.2) | 20 (42.5;20.3–57.8) | < 0.001* |
| Cefoxitin | 0 (0.0;0.0–8.2) | 1 (2.1;0.0–11.3) | 1.000 | |
| Cefuroxime | 3 (7.0;1.5–19.1) | 9 (19.1;9.2–33.3) | 0.166 | |
| Cefotaxime | 9 (20.9;10.0–36.0) | 13 (27.7;15.6–42.6) | 0.620 | |
| Ceftriaxone | 3 (7.0;1.5–19.1) | 3 (6.4; 1.3–17.5) | 1.000 | |
| Imipenem | Carbapenems | 5 (11.6;3.9–25.1) | 7 (14.9;6.2–28.3) | 0.885 |
| Tetracycline | Tetracyclines | 37 (86.0;72.1–94.7) | 1 (2.1;0.0–11.3) | < 0.001* |
| Chloramphenicol | Phenicols | 15 (34.9;21.0–51.0) | 0 (0.0;0.0–7.6) | < 0.001* |
| Trimethoprim sulphamethoxazole | Potentiated sulphonamides | 30 (69.8;53.9–82.8) | 2 (4.3;0.0–14.5) | < 0.001* |
| MDR (≥ 3 antimicrobials) | 38 (88.4;74.9–96.1) | 25 (53.2;38.1–67.9) | <0.001* | |
Statistical analysis: X2 test with Yate’s continuity correction; CI-Confidence Interval.
* Statistically significant.
Profiling of multidrug resistance (MDR) in E. coli and Salmonella spp
| MDR* Categories | Number of isolates | Number of isolates, n (%) | |
|---|---|---|---|
| Three | 5 | 0 (0.0) | 5 (20.0) |
| Four | 6 | 3 (7.9) | 3 (12.0) |
| Five | 10 | 8 (21.1) | 2 (8.0) |
| Six | 9 | 6 (15.8) | 3 (12.0) |
| Seven | 15 | 4 (10.5) | 11 (44.0) |
| Eight | 10 | 10 (26.3) | 0 (0.0) |
| Nine | 1 | 1 (2.6) | 0 (0.0) |
| Ten | 4 | 3 (7.9) | 1 (4.0) |
| Eleven | 2 | 2 (5.3) | 0 (0.0) |
| Thirteen | 1 | 1 (2.6) | 0 (0.0) |
*Characterization of multidrug resistance (MDR) by an isolate was defined as resistance to at least one agent in three or more different families of antimicrobials
Figure 3.The UPGMA dendrogram shows the relationships of E. coli and Salmonella spp. isolates (N = 90) based on phenotypic resistance to 16 antibiotics. Resistance and no resistance were coded as 0 and 1 respectively and using Ridom GmBH, Münster, Germany isolates were clustered by similarity of profile on the 16 antibiotics (antibiogram). We identified six major clusters spanning the seven-year period. Within these clusters, we observe several multi-resistant isolates marked with an arrow